Projects per year
Personal profile
Biography
Research interests
The major objective of our research is to understand the factors that lead to diabetic retinopathy (DR) and retinopathy of prematurity (ROP) in order to develop new treatment targets. Our research is conducted in animal models of retinopathy to ultimately translate our findings to patient studies. Our established network of basic scientists as well as clinical researchers and ophthalmologists (see below), allows this research to move rapidly forward and is enhanced by the new facilities and resources available in the Department of Diabetes.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Diabetes
- Diabetic retinopathy (DR)
- retinopathy of prematurity (ROP)
Collaborations and top research areas from the last five years
-
Does boosting the adaptive immune system reduce hypertensive diabetic retinopathy?
1/01/19 → 31/12/19
Project: Research
-
Fiber supplementation for the treatment of diabetic retinopathy
Deliyanti, D. (Primary Chief Investigator (PCI)), Wilkinson-Berka, J. (Chief Investigator (CI)) & Figgett, W. (Chief Investigator (CI))
1/01/19 → 31/12/19
Project: Research
-
Interactions between vasoactive factors and adaptive immunity in diabetic retinopathy
Jerome, J. R. & Wilkinson-Berka, J.
5/04/18 → 4/04/21
Project: Research
-
Modulating diet and the immune system to treat diabetic retinopathy
Deliyanti, D. & Wilkinson-Berka, J.
1/01/18 → 31/12/18
Project: Research
-
Tetraspanin CD82 restrains phagocyte migration but supports macrophage activation
McGowan, E. N. S., Wong, O., Jones, E., Nguyen, J., Wee, J., Demaria, M. C., Deliyanti, D., Johnson, C. J., Hickey, M. J., McConville, M. J., Wilkinson-Berka, J. L., Wright, M. D. & Binger, K. J., 15 Jul 2022, In: iScience. 25, 7, 21 p., 104520.Research output: Contribution to journal › Article › Research › peer-review
Open Access8 Citations (Scopus) -
Angiotensin II and aldosterone: Co-conspirators in ocular physiology and disease
Wilkinson-Berka, J. L. & Behar-Cohen, F., May 2020, In: Experimental Eye Research. 194, 2 p., 108005.Research output: Contribution to journal › Editorial › Other › peer-review
6 Citations (Scopus) -
Angiotensin II and aldosterone activate retinal microglia
Rana, I., Suphapimol, V., Jerome, J. R., Talia, D. M., Deliyanti, D. & Wilkinson-Berka, J. L., Feb 2020, In: Experimental Eye Research. 191, 7 p., 107902.Research output: Contribution to journal › Article › Research › peer-review
32 Citations (Scopus) -
Lung and Eye Disease Develop Concurrently in Supplemental Oxygen–Exposed Neonatal Mice
Wickramasinghe, L. C., Lau, M., Deliyanti, D., Gottschalk, T. A., van Wijngaarden, P., Talia, D., Johnson, C., Wilkinson-Berka, J. L., Tsantikos, E. & Hibbs, M. L., Sept 2020, In: American Journal of Pathology. 190, 9, p. 1801-1812 12 p.Research output: Contribution to journal › Article › Research › peer-review
14 Citations (Scopus) -
Nox (NADPH Oxidase) 1, Nox4, and Nox5 Promote Vascular Permeability and Neovascularization in Retinopathy
Deliyanti, D., Alrashdi, S. F., Touyz, R. M., Kennedy, C. R., Jha, J. C., Cooper, M. E., Jandeleit-Dahm, K. A. & Wilkinson-Berka, J. L., 1 Apr 2020, In: Hypertension. 75, 4, p. 1091-1101 11 p.Research output: Contribution to journal › Article › Research › peer-review
50 Citations (Scopus)